Elevidys has been given full approval to treat ambulatory patients with DMD, with an accelerated approval in non-ambulatory ...

Making good on his promise to move with "historic speed and strength", in his first weeks back in office President Donald ...

That is the conclusion of a study in The Lancet, which has tracked the take-up of childhood vaccinations for diseases like ...

The STAAR trial showed that a one-shot dose of ST-920 – now known as isaralgagene civaparvovec – was able to improve kidney ...

Trying to tackle all challenges at once will likely cause even more issues in the future; instead of spreading out, focus on ...

The EU approval is the first for the drug, although the FDA in the US is due to deliver its verdict on it by 29th July, and ...

Lung cancer proved the second-most discussed cancer type during ASCO 2025, totalling 2,995 mentions by more than 530 HCPs. As ...

Antibody-drug conjugates (ADCs) hit the scene in oncology many moons ago – in fact, this year marks 25 years since the first ...

Cambridge, Massachusetts-based Nuvalent has reported the results of its phase 1/2 ARROS-1 trial of zidesamtinib in previously ...

The JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...